These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30809381)

  • 21. Trends in antibiotic susceptibility and incidence of late-onset Klebsiella pneumoniae neonatal sepsis over a six-year period in a neonatal intensive care unit in Karachi, Pakistan.
    Saleem AF; Qamar FN; Shahzad H; Qadir M; Zaidi AK
    Int J Infect Dis; 2013 Nov; 17(11):e961-5. PubMed ID: 23759260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors in acquiring multidrug-resistant Klebsiella pneumoniae infections in a hospital setting in Saudi Arabia.
    Ibrahim ME
    Sci Rep; 2023 Jul; 13(1):11626. PubMed ID: 37468757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic epidemiology of Klebsiella pneumoniae in Italy and novel insights into the origin and global evolution of its resistance to carbapenem antibiotics.
    Gaiarsa S; Comandatore F; Gaibani P; Corbella M; Dalla Valle C; Epis S; Scaltriti E; Carretto E; Farina C; Labonia M; Landini MP; Pongolini S; Sambri V; Bandi C; Marone P; Sassera D
    Antimicrob Agents Chemother; 2015 Jan; 59(1):389-96. PubMed ID: 25367909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of novel sequence type of carbapenem-resistant New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in the neonatal intensive care unit of an Indian hospital.
    Ahmad N; Ali SM; Khan AU
    Int J Antimicrob Agents; 2019 Apr; 53(4):525-529. PubMed ID: 30578964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
    BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
    Benthall G; Touzel RE; Hind CK; Titball RW; Sutton JM; Thomas RJ; Wand ME
    Int J Antimicrob Agents; 2015 Nov; 46(5):538-45. PubMed ID: 26364845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for the first episode of Klebsiella pneumoniae resistant to carbapenems infection in critically ill patients: a prospective study.
    Mantzarlis K; Makris D; Manoulakas E; Karvouniaris M; Zakynthinos E
    Biomed Res Int; 2013; 2013():850547. PubMed ID: 24455733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
    Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
    Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit.
    Vardakas KZ; Matthaiou DK; Falagas ME; Antypa E; Koteli A; Antoniadou E
    J Infect; 2015 Jun; 70(6):592-9. PubMed ID: 25447713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study.
    Ishii J; Nishikimi M; De Bus L; De Waele J; Takaba A; Kuriyama A; Kobayashi A; Tanaka C; Hashi H; Hashimoto H; Nashiki H; Shibata M; Kanamoto M; Inoue M; Hashimoto S; Katayama S; Fujiwara S; Kameda S; Shindo S; Komuro T; Kawagishi T; Kawano Y; Fujita Y; Kida Y; Hara Y; Yoshida H; Fujitani S; Shime N;
    Microbiol Spectr; 2024 Jul; 12(7):e0034224. PubMed ID: 38864641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidrug Resistance Mechanisms of Carbapenem Resistant Klebsiella pneumoniae Strains Isolated in Chongqing, China.
    Yan J; Pu S; Jia X; Xu X; Yang S; Shi J; Sun S; Zhang L
    Ann Lab Med; 2017 Sep; 37(5):398-407. PubMed ID: 28643488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012.
    van der Steen M; Leenstra T; Kluytmans JA; van der Bij AK;
    PLoS One; 2015; 10(9):e0138088. PubMed ID: 26381746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality.
    Papadimitriou-Olivgeris M; Marangos M; Fligou F; Christofidou M; Sklavou C; Vamvakopoulou S; Anastassiou ED; Filos KS
    Diagn Microbiol Infect Dis; 2013 Oct; 77(2):169-73. PubMed ID: 23886789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of therapy and strain type on outcomes in urinary tract infections caused by carbapenem-resistant Klebsiella pneumoniae.
    van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Kaye KS; Bonomo RA
    J Antimicrob Chemother; 2015 Apr; 70(4):1203-11. PubMed ID: 25492391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster.
    Antoniadou A; Kontopidou F; Poulakou G; Koratzanis E; Galani I; Papadomichelakis E; Kopterides P; Souli M; Armaganidis A; Giamarellou H
    J Antimicrob Chemother; 2007 Apr; 59(4):786-90. PubMed ID: 17307769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for outbreaks of multidrug-resistant Klebsiella pneumoniae in critical burn patients.
    Sánchez M; Herruzo R; Marbán A; Araujo P; Asensio MJ; Leyva F; Casado C; García-de-Lorenzo A
    J Burn Care Res; 2012; 33(3):386-92. PubMed ID: 21979841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Extended-Spectrum Beta-Lactamases (ESBLs) and Antibiotic Susceptibility Patterns in Klebsiella pneumoniae in Western, Iran.
    Shakib P; Ramazanzadeh R; Taherikalani M; Nouri B
    Infect Disord Drug Targets; 2018; 18(2):156-163. PubMed ID: 28707597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Factors for Carbapenem-resistant
    Wang Z; Qin RR; Huang L; Sun LY
    Chin Med J (Engl); 2018 Jan; 131(1):56-62. PubMed ID: 29271381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia.
    Ariffin H; Navaratnam P; Mohamed M; Arasu A; Abdullah WA; Lee CL; Peng LH
    Int J Infect Dis; 2000; 4(1):21-5. PubMed ID: 10689210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
    Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.